Mortality measurement in transition: proof of principle for standardised multi-country comparisons* by Fottrell, Edward et al.
Mortality measurement in transition: proof of principle for
standardised multi-country comparisons*
Edward Fottrell
1, Kathleen Kahn
1,2, Nawi Ng
1,3, Benn Sartorius
2, Dao Lan Huong
4, Hoang Van Minh
4, Mesganaw
Fantahun
5 and Peter Byass
1
1 Department of Public Health and Clinical Medicine, Division of Epidemiology & Global Health, Umea ˚ Centre for Global Health
Research, Umea ˚ University, Umea ˚, Sweden
2 MRC⁄Wits Rural Public Health and Health Transitions Research Unit (Agincourt), School of Public Health, Faculty of Health Sciences,
University of Witwatersrand, Johannesburg, South Africa
3 Purworejo Health and Demographic Surveillance Site, Gadjah Mada University, Jogjakarta, Indonesia
4 FilaBavi Health and Demographic Surveillance Site, Hanoi, Vietnam
5 Butajira Rural Health Programme, Department of Community Health, Addis Ababa University, Addis Ababa, Ethiopia
Summary objective To demonstrate the viability and value of comparing cause-speciﬁc mortality across four
socioeconomically and culturally diverse settings using a completely standardised approach to VA
interpretation.
methods Deaths occurring between 1999 and 2004 in Butajira (Ethiopia), Agincourt (South Africa),
FilaBavi (Vietnam) and Purworejo (Indonesia) health and socio-demographic surveillance sites were
identiﬁed. VA interviews were successfully conducted with the caregivers of the deceased to elicit
information on signs and symptoms preceding death. The information gathered was interpreted using
the InterVA method to derive population cause-speciﬁc mortality fractions for each of the four settings.
results The mortality proﬁles derived from 4784 deaths using InterVA illustrate the potential of the
method to characterise sub-national proﬁles well. The derived mortality patterns illustrate four popu-
lations with plausible, markedly different disease proﬁles, apparently at different stages of health
transition.
conclusions Given the standardised method of VA interpretation, the observed differences in mor-
tality cannot be because of local differences in assigning cause of death. Standardised, ﬁt-for-purpose
methods are needed to measure population health and changes in mortality patterns so that appropriate
health policy and programmes can be designed, implemented and evaluated over time and place. The
InterVA approach overcomes several longstanding limitations of existing methods and represents a
valuable tool for health planners and researchers in resource-poor settings.
keywords verbal autopsy, epidemiologic transition, health and demographic surveillance systems,
mortality, developing countries, health metrics
Introduction
Epidemiological understanding of health and changing
morbidity and mortality patterns globally is limited by
inadequate measurement of population health status. Less
than one-third of deaths worldwide are assigned a cause-
of-death and this longstanding dearth of information,
almost exclusively in the world’s poorest countries, hinders
understanding of mortality patterns and associated health
challenges both within and across national boundaries
(Mathers et al. 2005). As many of the world’s poorer
countries experience epidemiological transitions (Ng et al.
2006; Tesfaye et al. 2007; Berhane et al. 2008), emerging
non-communicable diseases (NCDs) combined with old
and new infectious disease epidemics (Tollman et al.
2008), as well as humanitarian crises (Fottrell & Byass
2009) and natural disasters add to the burden of already
struggling health care systems and heighten the need for
reliable health statistics.
In the absence of routine death registration, verbal
autopsy (VA) methods gather information from a close
caregiver about the signs and symptoms of the deceased’s
terminal illness, as well as lifestyle behaviours and other
characteristics. This information is then used to derive
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pendent review of the data by local physicians who try to
reach consensus on cause of death (Snow & Marsh 1992;
Soleman et al. 2006). VA is considered a useful method for
cause-of-death ascertainment in otherwise data-poor set-
tings; however, the approach is not without limitations.
Non-standardised data-collection tools, varying skills of
VA interviewers, reporting biases and knowledge and
understanding of signs and symptoms of illness all affect
the ability to gather reliable VA data (Chandramohan et al.
1994). Once data have been gathered, concerns over inter-
observer agreement and lack of standardisation of physi-
cian review methods preclude meaningful comparisons of
cause-speciﬁc mortality between regions and over time
(Todd et al. 1994). In addition, the time that physicians
must devote to assessing large numbers of VAs is far from
ideal in areas with insufﬁcient medical personnel. Such
issues in interpreting VA data have been tackled with
efforts culminating in the development of various algo-
rithmic approaches based on the concept of distilling the
process of physician review into standardised rules
(Murray et al. 2007). Whilst being more transparent and
repeatable, algorithmic procedures make it impossible to
consider parallel possibilities of multiple causes of death
and very often require speciﬁc questionnaires that are
designed for speciﬁc contexts (Fottrell & Byass 2010).
InterVA (http://www.interva.net) is an approach to VA
interpretation that aims to overcome the longstanding
limitations of alternative methods. Applying Bayes’ theo-
rem to derive probable causes of death from VA data, the
method simultaneously adjusts the probability of each of a
ﬁnite list of causes according to afﬁrmative answers to a
speciﬁed list of signs and symptoms, and calculates the
likelihood of each cause. The method has been shown,
within single settings, to produce comparable VA-derived
cause-speciﬁc mortality fractions (CSMFs) to physician
review whilst being 100% standardised – the same set of
indicators, signs and symptoms will always lead to the
same probable cause of death (Byass et al. 2003, 2006;
Fantahun et al. 2006; Fottrell et al. 2007; Tensou et al.
2007). Application of the method in intervention and
impact evaluation research in various settings has also been
satisfactory (Bell & Qomariyah 2007; Bell et al. 2008;
WHO, 2009), and a recent review of the INDEPTH
network of Health and Demographic Surveillance Sites
(Indepth, 2008) called for all sites to use the method for
coding of causes of death because such approaches
represent ‘the only viable strategy to produce timely and
comparable cause-of-death statistics’ (Kinyanjui &
Timaeus 2010).
Using InterVA and VA data from Health and Demo-
graphic Surveillance Sites (HDSS) in Ethiopia, South
Africa, Vietnam and Indonesia, this paper compares
mortality across four culturally diverse countries at
different stages of socioeconomic development. To the best
of our knowledge, this is the ﬁrst demonstration of cause-
of-death comparisons based on VA across diverse devel-
oping-country settings using a completely standardised
interpretation tool. Our primary aim was to demonstrate
the viability and value of making systematic comparisons
of cause-speciﬁc mortality patterns across different set-
tings. This paper does not attempt to draw deﬁnitive or
representative conclusions concerning mortality patterns in
the four countries that happen to be represented in this
example.
Methods
Health and socio-demographic surveillance involves the
registration of populations within clearly circumscribed
geographic areas and subsequent prospective follow-up
through regular household surveys that systematically
record all births, deaths and migrations. This approach
underlies the Butajira (Ethiopia), Agincourt (South Africa),
FilaBavi (Vietnam) and Purworejo (Indonesia) health and
demographic surveillance sites (HDSS) included in this
study, each a member of the INDEPTH network. Each of
these HDSSs employ broadly similar methods which are
described in detail elsewhere (Chuc & Diwan 2003; Ng
2006; Kahn et al. 2007; Berhane et al. 2008) and are
summarised in Table 1. VA constitutes a routine aspect
of the longitudinal health and demographic surveillance
in each of the sites and attempts are made to gather VA
data for every death. Despite broadly similar approaches
in health and demographic surveillance operations, the
speciﬁc methodologies, such as timing of interview, and
the tools utilised for VA data capture differ between
sites.
Selecting a relatively narrow time period for which VA
data were available from each participating HDSS and
which enabled as much temporal overlap between sites as
possible, indicators were extracted for each death from
each site’s VA database and entered into a batch ﬁle for
processing in InterVA using Microsoft FoxPro version 9
software. The process of preparing data for InterVA is
straightforward, with relevant indicators being entered into
a single spreadsheet format. This can be performed
manually but would be time consuming for a large number
of cases. Therefore, simple computer procedures were
written to select the relevant information from the HDSS
VA databases and transform it into the batch ﬁle, spread-
sheet format used by InterVA. The process of mapping VA
database variables (conceptually the same as VA ques-
tionnaire questions) to equivalent indicators in InterVA is
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mation comes from questions that are easily associated
with indicators built into InterVA.
Applying Bayes’ theorem, the computer-based InterVA
approach calculates the probability of each of a ﬁnite list of
causes (C) given the presence of speciﬁc signs, symptoms or
indicators (I), for which the probability of reporting each
indicator given a speciﬁc cause (P(I|C)) and the population-
level probability of each cause among all deaths (P(C)) has
been estimated (Byass et al. 2006). In mathematical terms:
PðCjIÞ¼
PðIC j Þ PðCÞ
PðIC j Þ PðCÞþPðI ! j CÞ Pð!CÞ
where P(!C) is the probability of not (C).
The prior probabilities P(I|C) and P(C) are derived
from an expert physician consensus process whereby
probabilities were estimated based on a range of 11
approximate quantitative probabilities associated with
semi-qualitative descriptors that included ‘absolutely
never’ (P = 0), ‘virtually never’ (P = 0.001), ‘uncommon’
(P = 0.002, P = 0.005, P = 0.01), ‘moderately
often’ (P = 0.02, P = 0.05, P = 0.10), ‘frequently’
(P = 0.20, P = 0.50) and ‘almost always’ (P = 0.99). Thus,
each step increase on the scale resulted in an approximate
doubling of the probability. The physicians involved in
this process were selected from a range of settings and
clinical backgrounds, thus minimising the risk of develop-
ing InterVA based too closely to any one geographical
region or medical discipline (Byass et al. 2006).
Using the above equation, the probability of occurrence
of each indicator (I1…In) and each possible cause of death
(C1…Cm) can be determined according to a matrix of
P((I1…In)⁄(C1…Cm)). The set of indicators and causes
included in the model was inﬂuenced by established VA
questionnaires and the expert consensus process described
above, and can be viewed elsewhere (Byass et al. 2006;
InterVA). Symptoms, histories and circumstances of death
reported in either the open narrative or closed questions in
VA interviews can be utilised. Probabilities in InterVA are
only affected by afﬁrmative answers to any of the indica-
tors; therefore, negative, missing and unknown answers do
not affect probabilities, making the model more readily
amenable to data collected using different tools. The fact
that not reporting symptoms does not reduce or eliminate
the possibility of any speciﬁc diagnoses is also important in
minimising any bias that may arise from the fact that
physician-derived prior probabilities could overestimate
the number of recognisable and reported symptoms asso-
ciated with speciﬁc causes of death in the general popula-
tion as opposed to clinical samples. InterVA is currently
designed to display up to three likely causes of death with
corresponding likelihoods and an overall certainty factor
for each death. Fewer than three causes will be displayed if
the probability of the third (or second) cause is less than
80% of the probability of the preceding cause. Cases with
insufﬁcient VA data to decisively alter the cause probabil-
ities are identiﬁed by InterVA as ‘indeterminate’.
To derive population-level CSMFs, the sum of likeli-
hoods for each cause category is divided by the sum of
the likelihoods for all causes, thus splitting individual
deaths between multiple causes weighted by the cause
probabilities. For example, if a case is assigned two
possible causes, A and B, with likelihoods of 60% and
40%, respectively, then 0.6 contributes to the overall
burden of cause A category and 0.4 contributes to the
cause B category. The sum of all fractions in each cause
category divided by the total number of deaths represents
the population CSMF. To facilitate comparisons and
with expert guidance from physician-researchers, Inter-
VA-derived causes of death were grouped into broad
categories of epidemiological and public health interest,
namely cause groupings for which public health inter-
ventions would be similar.
In each HDSS, verbal informed consent is obtained at
household level at every update visit and community
consent from civic and traditional leadership was secured
at the start of surveillance activities. In addition, the
surveillance-based studies in Ethiopia, South Africa,
Table 1 Summary of period, populations and VA data included in the study from each of the demographic and health surveillance sites
Country Ethiopia South Africa Vietnam Indonesia
HDSS Butajira Agincourt FilaBavi Purworejo
Calendar period 2003–2004 1999–2004 1999 2000–2002
Number of deaths 367 3516 221 1982
Person-years of observation 52 964 394 480 43 444 167 895
Crude mortality rate (per 1000 p-years) 6.9 8.9 5.1 11.8
VAs included in study (% of all deaths) 351 (96%) 3380 (95%) 189 (86%) 864 (44%)
Further information Berhane et al. (2008) Kahn et al. (2007) Chuc and Diwan (2003) Ng (2006)
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committees at the Universities of Addis Ababa, Witwa-
tersrand, Hanoi and Gadjah Mada, respectively.
Results
Verbal autopsy data were available for 351 deaths from
Butajira (96% of all deaths), 3380 from Agincourt (95%),
189 from FilaBavi (86%) and 864 from Purworejo (44%)
between 1999 and 2004 and all were included in the study.
Characteristics of the sites and the details of the VA data
from each site are summarised in Table 1. Age distribu-
tions of all-cause mortality are shown by site in Figure 1.
Of all VA cases, 60 (1.3%) were assigned three probable
causes of death by InterVA, two causes were assigned in
592 (12.4%) cases and a single cause was assigned in 3822
(79.9%) cases. In total, 310 (6.5%) VAs provided insuf-
ﬁcient information for cause-of-death ascertainment
(ranging from 7% in Agincourt to 12% in FilaBavi), and
these cases were classiﬁed by InterVA as ‘indeterminate’.
Speciﬁc causes of death were grouped into broad cause
classiﬁcations. Figure 2 shows the broadest groupings of
cause-of-death categories for each country, indicating the
major CSMF burdens in terms of infectious, non-commu-
nicable and external causes. More detail is provided in
Table 2, with the categories shown in Figure 2 broken
down into causes with broadly similar aetiologies, risk
factors and health care implications. In Butajira (Ethiopia),
the greatest burden of mortality was attributed to acute
infectious causes, which include diarrhoeal diseases,
malaria, meningitis, tetanus and pneumonia⁄sepsis. Whilst
the overall burden of infectious causes of death in
Agincourt (South Africa) was similar to that in Butajira,
the majority of these were from chronic infectious causes of
HIV-related death and pulmonary tuberculosis; acute
infections represented approximately 10% of deaths in the
South African data. There was also a clear burden of NCDs
in this population, with approximately 20% of deaths
being caused by cardiovascular diseases, chronic liver
disease, respiratory diseases (excluding pneumonia),
diabetes or malignancy. In FilaBavi (Vietnam), diseases of
the cardiovascular system, liver disease and malignant
neoplasms characterised the mortality pattern; however,
more than 20% of deaths were attributed to acute
infections. CSMFs for Purworejo (Indonesia) showed the
greatest burden to be from NCDs, with over 60% of deaths
being because of chronic conditions, predominantly car-
diovascular diseases.
The ‘maternal⁄infant’ cause category consists of deaths
identiﬁed as perinatal asphyxia, congenital malformations
or pre-term delivery as well as adult female deaths likely to
be related to pregnancy. The ‘other’ category presented in
the results represents diagnoses of diseases of the nervous
system, haemoglobinopathies, kwashiorkor and other
malnutrition-related deaths, and digestive and urinary
diseases not classiﬁed in any other category. The overall
CSMF of these ‘other’ causes was similar in all settings.
The burdens of external causes of deaths (which include
accidental deaths, road trafﬁc injuries, homicide and
suicide) were particularly prominent in Agincourt and
FilaBavi. However, InterVA’s ability to differentiate
between fairly speciﬁc causes revealed markedly different
precise causes that go some way to characterising the
different settings (Figure 3).
Discussion
Through a standardised approach to VA interpretation,
this study provides a uniquely objective view of mortality
patterns in rural areas of four geographically and socio-
economically diverse countries. Although the choice of
countries in this study was pragmatic, calendar periods
differ between settings and the data are not necessarily
representative of the countries or regions from which they
come, the results demonstrate the potential of standardised
methods of VA assessment for providing useful insights
into health proﬁles on both a local and global level.
VA is generally considered a blunt tool for measuring
mortality at the individual level; however, the InterVA-
derived CSMFs in this study demonstrate the potential of
the method to characterise sub-national proﬁles well. It is
not the intention of our study to describe in detail the
epidemiology and explanations for the different mortality
proﬁles seen in each of the study settings. Any thorough
epidemiological evaluation and discussion of the differ-
ences between settings would require careful selection of
time periods and a detailed discussion of how variations in
data capture processes might explain some of the
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Figure 1 Age distributions of all-cause mortality from the four
health and demographic surveillance sites.
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less, the mortality patterns identiﬁed using InterVA are
plausible, illustrating populations with markedly different
mortality proﬁles and apparently at different stages of
health transition.
The breakdown of external causes in Agincourt and
FilaBavi is also highly plausible (Figure 3). The external
causes for FilaBavi are predominately comprised of acci-
dental deaths, most commonly home and work-related
accidents and drowning in children under 15 years (results
not shown), reﬂecting the rural, agricultural setting and the
hazardous paddy ﬁelds that characterise the physical
environment (Hang et al. 2004). The breakdown of
external causes in Agincourt shows quite a different
pattern, where, according to InterVA, 40% of these deaths
are a result of violence; a ﬁgure that is similar to previously
reported estimates (Kahn et al. 1999). The distinct age-
patterns of all-cause mortality between settings (Figure 1)
may explain the differences in cause patterns observed to
some extent as certain causes are more common in certain
age groups. Derivation of age- and⁄or sex-speciﬁc mortal-
ity proﬁles, or indeed stratiﬁcation by any parameter of
interest, can easily be done using InterVA providing the
necessary data are available. Such comparisons of InterVA-
derived causes for adult female deaths in Burkina Faso and
Indonesia showed distinct patterns despite underlying
comparability of age and reproductive health risks (Byass
et al. 2009). This demonstrates that the InterVA method
does not simply rely on pre-judgement of causes based on
100%
Indet
Maternal/infant/nutritional
External
NCD
80%
60%
40%
20%
0%
Ethiopia South Africa Vietnam Indonesia
Chronic infectious
Acute infectious
Indet
External
NCD
NCD
NCD
Chronic infectious
Acute infectious
Acute infectious
Indet Indet
External
External Maternal/infant/nutritional
Acute infectious
Chronic infectious
Figure 2 Broad groups cause classiﬁcations by country based on population cause-speciﬁc mortality fractions determined by InterVA for
4784 deaths from Butajira (Ethiopia), Agincourt (South Africa), FilaBavi (Vietnam) and Purworejo (Indonesia).
Table 2 Cause-speciﬁc mortality fractions by country as deter-
mined by InterVA for 4784 deaths from Ethiopia, South Africa,
Vietnam and Indonesia
Cause of death
Ethiopia South Africa Vietnam Indonesia
Butajira Agincourt FilaBavi Purworejo
Infection 45.4 9.2 22.9 9.5
HIV 3.4 24.5 0.0 1.2
TB 17.4 26.0 1.1 8.4
Maternal⁄infant 7.5 0.9 2.6 0.4
CVD 3.1 6.5 24.1 41.5
Liver 4.7 5.3 10.0 8.7
Malignancy 1.2 1.0 10.5 2.9
Diabetes 0.3 3.9 0.3 2.5
Respiratory 0.8 3.5 0.0 6.5
External causes 3.8 9.2 13.2 4.3
Other 3.5 2.8 3.0 2.5
Indeterminate 8.9 7.0 12.3 11.5
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principles to a whole range of indicators to derive causes
on a case-by-case basis.
Whilst standardised interpretation of VA data is a major
strength of this study, it must be acknowledged that,
although similar, speciﬁc ﬁeld procedures and tools used to
gather VA data were not standardised between the four
settings and none were speciﬁcally related to the InterVA
method. As such not all indicators available in each
country’s data were built into the probabilistic model and
speciﬁc indicators that are built into the model were not
gathered in all settings. InterVA was intentionally designed
not to relate speciﬁcally to any particular setting or
questionnaire because it is important to accommodate data
from different sources. Nevertheless, a need to refocus
methodological developments on the entire VA process,
including both data capture and interpretation may be
appropriate. Recent efforts by the INDEPTH network, as
well as WHO, to produce standardised and freely available
VA data-collection instruments (Indepth, 2006; Baiden
et al. 2007) are useful in this respect, but very little is
known about how questionnaire design and data com-
pleteness affect the reliability and utility of VA data,
whichever method of interpretation is used. Empirical
research into these issues alongside developments in
interpretation methods may offer new opportunities for
improving cause-speciﬁc mortality data globally.
The process of mapping and translating VA database
variables to equivalent indicators in InterVA is straight-
forward. Nevertheless, variability in questionnaires and
local interpretations of medical terms requires some local
input and interpretation to ensure correct mapping,
particularly if information from open-ended sections is to
be included. Standardisation of questionnaires would
further minimise possibilities for variability in the mapping
and translation process, and further research is needed to
establish the value of open-ended information for com-
puter interpretation programs. Once mapping has been
established, simple computer queries can be written to fully
automate the transformation of information from VA
databases into indicators for InterVA. This provides
opportunities for highly efﬁcient routine procedures for
timely, standardised cause-of-death ascertainment from
VA data, as recommended for all INDEPTH health and
demographic surveillance sites (Kinyanjui & Timaeus
2010).
Validation of the InterVA method is difﬁcult to achieve.
Because of the biases and limitations of reference standards
against which cause-of-death diagnoses can be compared,
validation of any VA method against medical,
100%
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Figure 3 Breakdown of external causes of death in Agincourt (South Africa) and FilaBavi (Vietnam).
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Fantahun et al. 2006; Setel et al. 2006) and absolute gold-
standard assessments of cause-of-death that can be applied
to deaths that occur at home are unlikely to exist (Quigley
et al. 1999). Nevertheless, VA diagnoses correlated with
reference diagnoses continue to be considered useful in
illuminating some of the limitations and misclassiﬁcation
errors in VA. As such, further opportunities for evaluating
various aspects of InterVA do exist, including comparisons
with mortality proﬁles derived for population sub-samples
who have had contact with health facilities. Nevertheless,
to consider such comparisons as validation studies would
be misleading and ultimately unproductive. The optimal
utility and application of VA must be judged within a
broader conceptualisation of cause of death that recognises
public health needs rather than perceived needs to satisfy
traditional, clinical ideals of cause-of-death measurement
and utility (Fottrell & Byass 2010). The outcome of such
comparisons must be interpreted carefully and, rather than
validity, focus on plausibility, appropriateness and useful-
ness in ﬁlling important gaps in mortality data (Kaufman
et al. 1997; Setel et al. 2006, 2006; Fottrell & Byass 2010).
In this sense, InterVA has been shown to have good
comparability to physician review and offers an efﬁcient
and practical tool for cause-speciﬁc mortality assessments
(Byass et al. 2003, 2006; Fantahun et al. 2006; Tensou
et al. 2007). Still, there remain opportunities for cause-of-
death misclassiﬁcation, not least for HIV and TB (Tollman
et al. 2008), which is why these causes were combined in
the current analysis. It should be noted, however, that the
composition of the HIV⁄TB cause group differs consider-
able between the four sites. Substantially, fewer TB deaths
in Vietnam and Indonesia are related to HIV compared to
Ethiopia and (in particular) South Africa, and this was
reﬂected in the InterVA output (results not shown).
Grouping of causes of death into broad categories is
useful for representing major cause-of-death burdens in
relation to causation and opportunities for intervention.
Consolidating causes, with multiple, related causes falling
into a single category is consistent with the philosophy of
focusing on cause categories and cause deﬁnitions of public
health importance and broad care needs rather than
traditional clinical and pathology approaches (Pacque-
Margolis et al. 1990; Bang & Bang 1992; Marsh et al.
1995; Quigley 2005; Thatte et al. 2009). Reports of
selective interventions reducing deaths to non-targeted
diseases further support the use of consolidated cause
categories (Marsh et al. 1995). Nevertheless, characterising
certain causes is not always straightforward. For example,
pneumonia could be characterised as a respiratory illness
[as is done in the International Classiﬁcation of Diseases
version 10 (WHO, 2006)] but in this analysis is charac-
terised as an infectious disease, partly because of difﬁculties
of distinguishing between pneumonia and sepsis in very
young children. Similarly, the model does not currently
specify types of malignancy, although in cases where
additional causes are assigned (such as respiratory disease),
these can shed some light on the manifestation of the ﬁnal
illness. There is scope to overcome these difﬁculties by
reﬁning InterVA to differentiate further within broad cause
categories as has been done for maternal deaths (Fottrell
et al. 2007) and work is currently ongoing to improve
speciﬁc diagnoses of causes of death in the neonatal period
(Vergnano & Fottrell 2008).
The methodological limitations in comparing cause-
speciﬁc mortality between settings using poorly standar-
dised VA methods are major (Adjuik et al. 2006). Some
studies have utilised expert and data-derived algorithms in
an attempt to standardise interpretation (Quigley et al.
2000; Lopman et al. 2006); however, algorithmic
approaches have important limitations, such as the inabil-
ity to consider parallel possibilities of causes of death
(Chandramohan et al. 1998; Setel et al. 2006; Fottrell &
Byass 2010). Furthermore, by selecting single causes of
death for each case, traditional algorithmic methods can
lose vital information about co-morbid conditions, thereby
distorting mortality estimates and underestimating poten-
tial gains from health interventions. InterVA overcomes
these problems by weighting the importance of signs and
symptoms in relation to speciﬁed causes of death and
simultaneously adjusting the overall likelihood of each
cause based on the reported signs and symptoms. This
method may, therefore, more accurately reﬂect the inter-
action of different diseases that lead to death and may
provide a more complete representation of the burden of
diseases at the population level than has previously been
possible. As such, this approach may represent a solution
to the longstanding VA dilemma of quantifying a differ-
ential diagnosis process for deaths from common symptom
complexes (Thatte et al. 2009). The reported probabilities
and certainty factor in InterVA may help with interpreta-
tion of results, corresponding with the opinion that
identifying possible causes and degrees of certainty of
derived causes may be more useful than deﬁnitive answers
in relation to VA data (Bang & Bang 1992).
Approximations of underlying probabilities in the
InterVA model are sufﬁcient to establish a workable model
(Byass et al. 2006). Derived through expert consensus,
these probabilities are based to some extent on the
assumption that responses to each indicator are indepen-
dent of all other indicators, which, strictly speaking, is
ﬂawed. Other techniques are being developed that use
facility data to establish the probability of reporting
speciﬁc symptoms given a speciﬁc cause (Murray et al.
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allow population and individual-level cause patterns to be
determined from VA data from a second dataset from
the population of interest. Ultimately, however, such
methods are limited in that they depend upon the
availability of high quality facility-based or valid mortality
data for modelling – a highly context-dependent
pre-requisite that cannot readily be met by the majority
of settings in Africa and elsewhere that need to use
VA methods. The extent to which results from population-
level InterVA are sensitive to the prior probabilities has not
been formally tested. However, given the somewhat
approximate design of the scale from which the probabil-
ities were selected, it is unlikely that variations in prior
probabilities a step or two in either direction will
dramatically affect population-level results. Further
systematic testing is planned to test this hypothesis.
For the time-being, therefore, InterVA offers a viable
tool for addressing the needs of public health decision-
makers and researchers who want to characterise popula-
tion health cheaply, efﬁciently and in a timely manner in
settings where little or no prior knowledge is available and
where VA data can be collected. Although the method may
lack some of the subtlety of physician review, its simplicity
and speed of data processing as well as the complete
certainty that any observed differences in cause-speciﬁc
mortality are a result of differences in recorded symptom
proﬁles rather than differences in the training, skills and
idiosyncrasies of coding physicians is a major advantage.
Future developments in conceptual and methodological
thinking around the issue of VA, combined with global
collaborations and enhanced data sharing (as exempliﬁed
by the current work) are essential to achieving the clarity
and consistency in health metrics needed to ﬁll mortality
data gaps at all levels.
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